Approximately 1.39 crore shares could be on the block, according to the report by CNBC-TV18 which cited sources.
At this offer price, the shares will be off-loaded at a 6% discount over Friday’s closing price of Rs 1,532. Today, Cipla shares settled higher by Rs 39.25 or 2.63% over Thursday’s closing price.
The promoters of Cipla had in May this year sold a 2.53% stake for Rs 2,751 crore in a block deal on the NSE. According to the NSE block deal data, Shirin Hamied, wife of MK Hamied, vice-chair and non-executive director on the Cipla board and her daughters Rumana Hamied, Samina Hamied, and Okasa Pharma Private Ltd, all categorized as promoter group, had then sold 2.04 crore shares at Rs 1,345 apiece.
The company in a stock exchange release said the stake sale was intended at raising funds for specific needs, including philanthropy.
The Drug had posted 15% growth in its consolidated net profit to Rs 1,303 crore for the quarter ended September 2024, compared with Rs 1,131 crore in the year- ago period. The profit was above the ET Now poll estimates of Rs 1,218 crore.Revenue from operations rose 6% year-on-year to Rs 7,051 crore in the July-September 2024 period as against Rs 6,678 crore in the last year period.The company reported an EBITDA growth of 12% year-on-year to Rs 1,886 crore in the second quarter.
Cipla shares have rallied 27% over the last one year which is an outperformance over NIfty in the same period. The index has delivered returns of 21% in the same period.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)